December 8, 2008 – Investigators say CORE 64 shows that CT angiography can accurately identify the presence and severity of obstructive coronary artery disease in symptomatic patients, but that it is not yet ready to replace invasive coronary angiography.

December 8, 2008 - As the next phase in validating advanced computed tomography technology in a clinical setting, Toshiba Medical Systems Corporation (TMSC) will support CORE 320, the largest worldwide multi-center trial comparing the effectiveness of 320-detector row dynamic volume CT to SPECT technology.

December 8, 2008 - Viatronix Inc., a developer of 3D imaging software, reported it received FDA 510(k) market clearance for its V3D-Cardiac module.

December 8, 2008 - ZOLL Medical Corp. said last week more than 12,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the ZOLL LifeVest Wearable Defibrillator by their physician since it was approved by the FDA in 2002.

The company said this represents more than 2,000 years of cumulative patient time wearing a LifeVest, and, in any given month, more than 1,000 patients are being protected from sudden death wearing the LifeVest, Zoll said.

December 8, 2008 - There has been much discussion in recent weeks of the 14-year-old patient from Holtz Children’s Hospital in Miami living without a heart for more than 100 days, but what has not been reported are the facts behind the struggle as to how initially and immediately treat the young patient in post-transplant failure.

December 8, 2008 - New research reveals patients with implantable cardioverter defibrillators (ICDs) who have had multiple, previous pocket procedures are at an increased risk of complications after ICD replacement.

The EmpowerCTA injector system offers both ACIST’s patented extravasation detection accessory (EDA) and a saline chase. This CT injector features air embolism protection, on-the-fly flow rate manipulation and syringe loading and arming at the injector.

Developers in New York are planning to build The World Product Centre, which will be reportedly the world’s first permanent international healthcare marketplace and education center.

December 5, 2008 - CeloNova BioSciences Inc. said this week it expanded the areas in which it is commercializing the CATANIA Coronary Stent System with NanoThin Polyzene-F, a stent system that has not had any stent thrombosis in clinical studies.

It is CE marked and available for purchase throughout Europe and now some Middle Eastern countries. CeloNova has received regulatory approval to increase the shelf life for the stent from two years to three years.

December 5, 2008 - Lebanon County, PA cardiologist Jeffrey L. Williams, M.D., MS, FACC, is the author of a study released in the Journal of Interventional Cardiology, “Feasibility of Myxomatous Mitral Valve Repair Using Direct Leaflet and Chordal Radiofrequency Ablation,” and is said to be the first in the world to describe a completely catheter-based intracardiac ablation approach to repair mitral valve prolapse causing severe mitral regurgitation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now